Showing results (121-130 of 205) with videos related to
Sort By:
Pageof 21
Psychopharmacology Bulletin|January 1, 1989
Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study GroupW A Hargreaves, J M Kane, P T Ninan, et al.Psychiatry Research|March 1, 1980
Can schizophrenia with premorbid asociality be genetically distinguished from the other forms of schizophrenia?F M Quitkin, A Rifkin, M T Tsuang, et al.Psychopharmacology Bulletin|January 1, 1995
Neuroleptic treatment of elderly patientsM G Woerner, J M Alvir, J M Kane, et al.Alcohol (Fayetteville, N.Y.)|February 6, 2008
Ethanol exposure of neonatal rats does not increase biomarkers of oxidative stress in isolated cerebellar granule neuronsCynthia J M Kane, Jason Y Chang, Paula K Roberson, et al.Surgical Oncology|December 29, 2000
Large, deep high-grade extremity sarcomas: when is a myocutaneous flap reconstruction necessary?J M Kane, J F Gibbs, B E McGrath, et al.The American Journal of Psychiatry|November 13, 1998
Prospective study of tardive dyskinesia in the elderly: rates and risk factorsM G Woerner, J M Alvir, B L Saltz, et al.British Journal of Pharmacology|September 1, 1992
MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like propertiesJ A Miller, M W Dudley, J H Kehne, et al.The American Journal of Psychiatry|June 1, 1993
Diabetes and development of tardive dyskinesiaM G Woerner, B L Saltz, J M Kane, et al.The American Journal of Psychiatry|May 1, 1984
Methylphenidate challenge as a predictor of relapse in schizophreniaJ A Lieberman, J M Kane, D Gadaleta, et al.The American Journal of Psychiatry|October 1, 1993
Polydipsia and tardive dyskinesia in chronic psychiatric patients--related disorders?D S Umbricht, B Saltz, S Pollack, et al.Pageof 21